[Strategy for the introduction of medications employed in delivering medical care to patients with sexually transmitted infections into the retail market].
Tha article is devoted to the development of strategy for entering the retail market of those medications intended for medical care delivery to patients with infections caught by sexual intercourse or genital contact. The use of the proposed strategy permits the optimization of the structure of necessary expenditures on material resources and enables one to successfully compete in the market of medications winning one's share in the market from competitors.